Skip to main content
  1. Market Insights
  2. Health
  3. Pharmacies
  4. OTC Products

Digestive & Intestinal Remedies (Pharmacies) - Russia

Russia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$210.77m in 2025.
  • Revenue is expected to show an annual growth rate (CAGR 2025-2029) of 1.72%, resulting in a market volume of US$225.63m by 2029.
  • In global comparison, most revenue will be generated China (US$3.41bn in 2025).
  • In relation to total population figures, per person revenues of US$1.47 are generated in 2025.

"

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

"
In-Scope
  • Natural and synthetic agents
  • Digestive medicines
  • Remedies against gastrointestinal complaints
Out-Of-Scope
  • Prescription medicines
  • Homeopathic remedies
  • Tea
OTC Products: market data & analysis - Cover

Market Insights report

OTC Products: market data & analysis
Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Analyst Opinion

    The Digestive & Intestinal Remedies (Pharmacies) market in Russia is experiencing steady growth due to changing customer preferences and favorable macroeconomic factors.

    Customer preferences:
    In recent years, there has been an increasing demand for digestive and intestinal remedies in Russia. This can be attributed to several factors. Firstly, there is a growing awareness among consumers about the importance of digestive health and the role it plays in overall wellness. As a result, more people are seeking remedies to address common digestive issues such as indigestion, bloating, and constipation. Secondly, the hectic and stressful lifestyles of modern Russians have led to a rise in digestive problems, creating a need for effective remedies. Lastly, the aging population in Russia is also contributing to the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues.

    Trends in the market:
    One of the key trends in the Digestive & Intestinal Remedies market in Russia is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives to synthetic medications. This trend is driven by a desire for safer and more sustainable options. As a result, there has been a rise in the availability and sales of herbal supplements and remedies targeting digestive health. Additionally, there is a growing trend towards self-care and self-medication, with consumers seeking over-the-counter remedies for minor digestive issues instead of visiting healthcare professionals.

    Local special circumstances:
    Russia has a unique healthcare system that influences the Digestive & Intestinal Remedies market. The country has a strong tradition of self-medication, with consumers often relying on pharmacies for advice and purchasing remedies without a prescription. This has created a favorable environment for the growth of the over-the-counter market for digestive and intestinal remedies. Additionally, the Russian market is characterized by a high level of competition, with both domestic and international players vying for market share. This competition has led to innovation in product offerings and marketing strategies to attract and retain customers.

    Underlying macroeconomic factors:
    The Digestive & Intestinal Remedies market in Russia is also influenced by macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and consumer spending. As a result, consumers have more purchasing power and are willing to spend on healthcare products, including digestive and intestinal remedies. Furthermore, the government has implemented healthcare reforms that have improved access to healthcare services and medications, further driving the demand for remedies in the market. In conclusion, the Digestive & Intestinal Remedies market in Russia is growing due to changing customer preferences, including a demand for natural remedies and a trend towards self-medication. The local special circumstances, such as the tradition of self-medication and high competition, also contribute to the market's development. Additionally, favorable macroeconomic factors, such as economic growth and healthcare reforms, have created a conducive environment for the market's growth.

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

    Modeling approach:

    Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

    Additional notes:

    The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    OTC Products: market data & analysis - BackgroundOTC Products: market data & analysis - Cover

    Explore more high-quality data on related topic

    Pharma e-commerce – statistics & facts

    The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)